71 related articles for article (PubMed ID: 28193024)
1. Evaluating Tumor-Associated Activity of Extracellular Sulfatase by Analyzing Naturally Occurring Substrate in Tumor Microenvironment of Hepatocellular Carcinoma.
Yu Y; Li H; Yang Y; Ding Y; Wang Z; Li G
Anal Chem; 2016 Dec; 88(24):12287-12293. PubMed ID: 28193024
[TBL] [Abstract][Full Text] [Related]
2. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
[TBL] [Abstract][Full Text] [Related]
3. hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.
Lai JP; Chien JR; Moser DR; Staub JK; Aderca I; Montoya DP; Matthews TA; Nagorney DM; Cunningham JM; Smith DI; Greene EL; Shridhar V; Roberts LR
Gastroenterology; 2004 Jan; 126(1):231-48. PubMed ID: 14699503
[TBL] [Abstract][Full Text] [Related]
4. HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity.
Seffouh A; Milz F; Przybylski C; Laguri C; Oosterhof A; Bourcier S; Sadir R; Dutkowski E; Daniel R; van Kuppevelt TH; Dierks T; Lortat-Jacob H; Vivès RR
FASEB J; 2013 Jun; 27(6):2431-9. PubMed ID: 23457216
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.
Tátrai P; Egedi K; Somorácz A; van Kuppevelt TH; Ten Dam G; Lyon M; Deakin JA; Kiss A; Schaff Z; Kovalszky I
J Histochem Cytochem; 2010 May; 58(5):429-41. PubMed ID: 20124094
[TBL] [Abstract][Full Text] [Related]
7. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
8. Affinity Selection of FGF2-Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells.
Wijesinghe SJ; Ling L; Murali S; Qing YH; Hinkley SF; Carnachan SM; Bell TJ; Swaminathan K; Hui JH; van Wijnen AJ; Nurcombe V; Cool SM
J Cell Physiol; 2017 Mar; 232(3):566-575. PubMed ID: 27291835
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate alterations in extracellular matrix structures and fibroblast growth factor-2 signaling impairment in the aged neurogenic niche.
Yamada T; Kerever A; Yoshimura Y; Suzuki Y; Nonaka R; Higashi K; Toida T; Mercier F; Arikawa-Hirasawa E
J Neurochem; 2017 Aug; 142(4):534-544. PubMed ID: 28547849
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.
Lamanna WC; Baldwin RJ; Padva M; Kalus I; Ten Dam G; van Kuppevelt TH; Gallagher JT; von Figura K; Dierks T; Merry CL
Biochem J; 2006 Nov; 400(1):63-73. PubMed ID: 16901266
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
[TBL] [Abstract][Full Text] [Related]
12. Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.
Yang XP; Liu L; Wang P; Ma SL
Chin Med J (Engl); 2015 May; 128(10):1384-90. PubMed ID: 25963362
[TBL] [Abstract][Full Text] [Related]
13. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.
Uchimura K; Morimoto-Tomita M; Bistrup A; Li J; Lyon M; Gallagher J; Werb Z; Rosen SD
BMC Biochem; 2006 Jan; 7():2. PubMed ID: 16417632
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro.
Alyoussef A; Al-Gayyar MMH
Biomed Pharmacother; 2018 Jul; 103():362-372. PubMed ID: 29669302
[TBL] [Abstract][Full Text] [Related]
15. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
[TBL] [Abstract][Full Text] [Related]
16. A conformational change in heparan sulfate 3-O-sulfotransferase-1 is induced by binding to heparan sulfate.
Edavettal SC; Carrick K; Shah RR; Pedersen LC; Tropsha A; Pope RM; Liu J
Biochemistry; 2004 Apr; 43(16):4680-8. PubMed ID: 15096036
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
18. Structural alteration of cell surface heparan sulfate through the stimulation of the signaling pathway for heparan sulfate 6-O-sulfotransferase-1 in mouse fibroblast cells.
Nishida M; Kozakai T; Nagami K; Kanamaru Y; Yabe T
Biosci Biotechnol Biochem; 2014; 78(5):770-9. PubMed ID: 25035978
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
20. Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling.
Kamimura K; Koyama T; Habuchi H; Ueda R; Masu M; Kimata K; Nakato H
J Cell Biol; 2006 Sep; 174(6):773-8. PubMed ID: 16966419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
